<SEC-DOCUMENT>0001654954-18-004605-index.html : 20180501
<SEC-HEADER>0001654954-18-004605.hdr.sgml : 20180501
<ACCEPTANCE-DATETIME>20180501154327
ACCESSION NUMBER:		0001654954-18-004605
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20180426
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
FILED AS OF DATE:		20180501
DATE AS OF CHANGE:		20180501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Medite Cancer Diagnostics, Inc.
		CENTRAL INDEX KEY:			0000075439
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				364296006
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-00935
		FILM NUMBER:		18795322

	BUSINESS ADDRESS:	
		STREET 1:		414 NORTH ORLEANS STREET
		STREET 2:		SUITE 502
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60610
		BUSINESS PHONE:		4078490290

	MAIL ADDRESS:	
		STREET 1:		414 NORTH ORLEANS STREET
		STREET 2:		SUITE 502
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60610

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CytoCore Inc
		DATE OF NAME CHANGE:	20060815

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOLECULAR DIAGNOSTICS INC
		DATE OF NAME CHANGE:	20011009

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMPERSAND MEDICAL CORP
		DATE OF NAME CHANGE:	19990527
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mdit8k_apr262018.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: mdit8k_apr262018.htm

</DOCUMENT>
</SEC-DOCUMENT>